世界卫生组织疟疾政策咨询小组：会议报告，2025年4月8日至10日

Meeting report, 8–10 April 2025 WHO Malaria PolicyAdvisory Group Meeting report, 8–10 April 2025 WHO Malaria Policy Advisory Group: meeting report, 8-10 April 2025 ISBN 978-92-4-011259-9 (electronic version)ISBN 978-92-4-011260-5 (print version) © World Health Organization 2025 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO;https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercialpurposes, provided the work is appropriately cited, as indicated below. In any use of this work, thereshould be no suggestion that WHO endorses any specific organization, products or services. The use ofthe WHO logo is not permitted. If you adapt the work, then you must license your work under the sameor equivalent Creative Commons licence. If you create a translation of this work, you should add thefollowing disclaimer along with the suggested citation: “This translation was not created by the WorldHealth Organization (WHO). WHO is not responsible for the content or accuracy of this translation. Theoriginal English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance withthe mediation rules of the World Intellectual Property Organization (http://www.wipo.int/amc/en/mediation/rules/). Suggested citation.WHO Malaria Policy Advisory Group: meeting report, 8-10 April 2025. Geneva:World Health Organization; 2025. Licence:CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data.CIP data are available athttp://iris.who.int/. Sales, rights and licensing.To purchase WHO publications, seehttps://www.who.int/publications/book-orders. To submit requests for commercial use and queries on rights and licensing, seehttps://www.who.int/copyright. Third-party materials.If you wish to reuse material from this work that is attributed to a third party,such as tables, figures or images, it is your responsibility to determine whether permission is neededfor that reuse and to obtain permission from the copyright holder. The risk of claims resulting frominfringement of any third-party-owned component in the work rests solely with the user. General disclaimers.The designations employed and the presentation of the material in thispublication do not imply the expression of any opinion whatsoever on the part of WHO concerning thelegal status of any country, territory, city or area or of its authorities, or concerning the delimitation ofits frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines forwhich there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they areendorsed or recommended by WHO in preference to others of a similar nature that are not mentioned.Errors and omissions excepted, the names of proprietary products are distinguished by initial capitalletters. All reasonable precautions have been taken by WHO to verify the information contained in thispublication. However, the published material is being distributed without warranty of any kind, eitherexpressed or implied. The responsibility for the interpretation and use of the material lies with thereader. In no event shall WHO be liable for damages arising from its use. This publication contains the report of the Malaria Policy Advisory Group (MPAG) and does notnecessarily represent the decisions or policies of WHO. Contents Abbreviations iv 1.Background1 2.Overview of the sessions2 2.1Update from the Global Malaria Programme2 2.3Status update on SNT of malaria interventions and strategiesmanual 2.4Gender equality, human rights and health equity in malariaresponse 2.5Update on malaria elimination11 2.6Update on vector control operational guidance13 2.7Drug resistance surveillance in Africa15 2.8Update on coordination of response to antimalarial drugresistance in Africa and establishment of subregional networks References 20 Annex 1. Declarations of interest 22 Annex 2. Agenda23 Annex 3. List of participants25 Abbreviations ACTartemisinin-based combination therapyG6PDglucose-6-phosphate dehydrogenaseIRSindoor residual sprayingITNinsecticide-treated netMFTmultiple first-line therapiesMPAGMalaria Policy Advisory Grouppfhrp2Plasmodium falciparumhistidine-rich protein 2SNTsubnational tailoringTEStherapeutic efficacy studyWHOWorld Health Organization 1.Background The World Health Organization (WHO) convened the Malaria Policy Advisory Group(MPAG) for its 27th meeting, held virtually and in person in Geneva, Switzerland, on8–10 April 2025. MPAG convenes twice annually to provide independent strategic adviceto WHO on technical issues related to malaria control and elimination. MPAG advisesthe WHO Director-General and the Global Malaria Programme specifically on: •appropriat